A kind of engineered blue algae and its preparation method and application
By adsorbing nano-gold particles and catalase active nanoparticles on the surface of cyanobacteria, engineered cyanobacteria with oxygen production and glycemic reduction functions were developed, which solved the problem of cyanobacteria in the prior art that only provides oxygen but no glycemic reduction functions, and achieved the correct Effective relief and improvement of diabetic retinopathy.
Patent Information
- Application Number
- CN202111203414.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-10-15
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The cyanobacteria used in the prior art for the treatment of diabetic retinopathy only have oxygen supply function and lacks glycemic lowering function, and cannot fundamentally solve the pathological process of diabetic retinopathy.
Develop an engineered cyanobacteria to form a new material with the dual functions of oxygen production and sugar reduction by adsorbing nano-gold particles and nano-gold particles with catalase activity on the surface of cyanobacteria. The material catalyzes glucose degradation in a high-sugar environment through a cascade reaction of nanoparticles, producing gluconic acid and hydrogen peroxide, and degrading hydrogen peroxide into non-toxic water and oxygen through another nanoenzyme.
It realizes the local oxygen supply and glucose-lowering functions in the eyes, alleviates fundus leakage caused by diabetic retinopathy, is safe and has high biocompatible materials, and does not show retinal detachment or bleeding after injection, which can quickly improve symptoms.
Smart Images

Figure CN113908179B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of medicine, and specifically relates to an engineered blue algae and a preparation method and application thereof. Background Art
[0002] Diabetic retinopathy (DR) is the most common microvascular complication in diabetic patients. The incidence rate is high in diabetic patients, and the quality of life of patients is seriously affected after the onset of the disease. It is the third leading cause of blindness after cataracts and glaucoma. According to incomplete statistics, the prevalence of DR in the diabetic population is 24.7% to 37.5%.
[0003] In the late stage of diabetes, it can cause fundus hypoxia, microaneurysms, new blood vessels, etc. Clinically, DR is divided into non-proliferative diabetic retinopathy (NPDR) without retinal neovascularization and proliferative diabetic retinopathy (PDR) with retinal neovascularization based on the presence of neovascularization.
[0004] At present, the common methods for treating diabetic retinopathy in clinical practice are laser photocoagulation, vitrectomy and intraocular injection of anti-angiogenic drugs. However, since the disease progression of different patients is different, a single treatment method often cannot achieve a good therapeutic effect. Laser photocoagulation is usually divided into three to four times, which increases the risk of surgery. Anti-angiogenic drugs have certain limitations due to their rapid metabolism and the need for multiple injections. Therefore, it is necessary to find a treatment method that can effectively alleviate the pathological progression of diabetic retinopathy and does not require multiple injections and is highly safe.
[0005] Blue algae have natural chlorophyll a, which can absorb blue and purple light in sunlight to produce oxygen through photosynthesis. In recent years, it has been used for oxygen supply to myocardial cells, tumor hypoxia treatment, infection treatment, etc. Compared with the disadvantages of poor oxygen supply capacity and low oxygen carrying efficiency of traditional materials, blue algae oxygen production can not only achieve efficient oxygen production, but also has good biocompatibility. It is a cheap and safe oxygen supply material, which has received widespread attention in the field of materials science.
[0006] However, the cyanobacteria used in the prior art for oxygen supply to myocardial cells, tumor hypoxia treatment, infection treatment, etc., only have the function of oxygen supply. However, diabetic retinopathy is an oxygen-deficient, high-sugar environment, and cyanobacteria that only have the ability to supply oxygen cannot fundamentally solve diabetic retinopathy. Summary of the invention
[0007] Therefore, the technical problem to be solved by the present invention is to overcome the defects of the prior art cyanobacteria that only have the oxygen supply function but not the blood sugar lowering function, thereby providing an engineered cyanobacteria and a preparation method and application thereof.
[0008] To this end, the present invention provides the following technical solutions:
[0009] The invention provides an engineered cyanobacteria, comprising cyanobacteria and nanoparticles adsorbed on the surface of the cyanobacteria. The nanoparticles are nanogold particles and nanoparticles with catalase activity.
[0010] Optional, every 10 7 The amount of gold nanoparticles adsorbed on each cyanobacteria is 20μg-80μg;
[0011] Every 10 7 The amount of the nanoparticles with catalase activity adsorbed on each cyanobacteria is 10 μg-100 μg.
[0012] Optionally, the nanoparticles having catalase activity are at least one of iridium nanoparticles, platinum nanoparticles, copper nanoparticles, manganese dioxide nanoparticles, and ferrosoferric oxide nanoparticles.
[0013] The present invention provides a method for preparing the above-mentioned engineered cyanobacteria, comprising the following steps:
[0014] The nano-gold is modified by a modifying agent to obtain nano-gold particles with positive surface charge;
[0015] The obtained nano-gold particles and nano-particles with catalase activity are added into a culture solution containing cyanobacteria for adsorption and solid-liquid separation, and the obtained solid is dispersed in ultrapure water to obtain the engineered cyanobacteria.
[0016] Optionally, the adsorption step is carried out by stirring at a constant speed of 20-200 rpm / min for 30-90 min at 20-25° C. until sufficient adsorption occurs. The mixture is centrifuged at 3000 rpm / min for 5 min to obtain a dark green precipitate, which is then redissolved in ultrapure water to obtain the engineered cyanobacteria.
[0017] Optionally, the modifier is at least one of mercaptoethylamine, L-cysteine, polyethyleneimine, and hexadecyltrimethylammonium bromide;
[0018] Optionally, the concentration of the modifier is 0.01wt%–0.5wt%;
[0019] Optionally, the solvent in the modifier is ultrapure water.
[0020] Optionally, the preparation method of the nano-gold particles and the nano-particles with catalase activity of the present invention is a conventional technology in the art. Specifically, the preparation method of the nano-gold is to use chloroauric acid as a raw material and a reducing agent to perform a reduction reaction to obtain the nano-gold; optionally, the temperature of the reduction reaction is 90-120°C and the time is 30-60min. For example, the preparation method of the nano-particles with catalase activity refers to Dual-Enzyme Characteristics of Polyvinylpyrrolidone-Capped Iridium Nanoparticles and Their Cellular Protective Effect against H2O2-Induced Oxidative Damage.ACS Appl Mater Interfaces.2015Apr 22;7(15):8233-42.doi:10.1021 / acsami.5b01271.Epub 2015 Apr9.PMID:25826467.
[0021] Optionally, the reducing agent is at least one of sodium citrate, sodium citrate-tannic acid, formaldehyde, propionaldehyde, formic acid, ascorbic acid, sodium borohydride, and hydroxylamine hydrochloride;
[0022] Optionally, the concentration of the reducing agent is 10mmol / L-100mmol / L.
[0023] Optionally, the cyanobacteria concentration in the cyanobacteria culture solution is 10 5 -10 8 cells / mL;
[0024] Optionally, the adsorption step is performed for 30-90 min;
[0025] Optionally, the concentration of cyanobacteria in the engineered cyanobacteria is 10 5 -10 9 cells / mL.
[0026] The present invention also provides an application of the engineered cyanobacteria or the engineered cyanobacteria prepared by the above preparation method in reducing blood sugar and producing oxygen.
[0027] The present invention also provides a use of the engineered cyanobacteria or the engineered cyanobacteria prepared by the above preparation method in preparing a drug for treating diabetic retinopathy.
[0028] The solvent in the cyanobacteria culture solution is any one of phosphate buffered saline (PBS), ultrapure water, and cyanobacteria culture medium (BG-11 Medium for Blue Green Algae).
[0029] The technical solution of the present invention has the following advantages:
[0030] The engineered cyanobacteria provided by the present invention comprises cyanobacteria and nanoparticles adsorbed on the surface of cyanobacteria, wherein the nanoparticles are nanogold particles and nanoparticles with catalase activity. The engineered cyanobacteria provided by the present invention is a novel engineered cyanobacteria with dual functions of oxygen production and local hypoglycemia and good biocompatibility. The raw materials of the material are green and environmentally friendly, can be safely applied in the eye, and the retinal structure does not change after injection, and retinal detachment, hemorrhage and the like do not occur. The material can be fully metabolized in the body, and the related symptoms can be quickly improved and alleviated. Through the local oxygen supply and hypoglycemic function of the material, the use of the material in the posterior segment of the eye will be beneficial to reduce fundus leakage caused by diabetic retinopathy.
[0031] The method for preparing the engineered cyanobacteria provided by the present invention comprises the following steps: modifying the nano-gold with a modifier to obtain nano-gold particles with positive surface charge; adding the obtained nano-gold particles and nano-particles with catalase activity to a culture solution containing cyanobacteria for adsorption to obtain the engineered cyanobacteria. The method is simple in material preparation and can be synthesized by simple steps under ordinary conditions. The materials are assembled by electrostatic adsorption to achieve simple preparation of engineered cyanobacteria; the modified nano-particles enhance their own stability and reduce toxicity, which can improve the biocompatibility of the nano-particles and cyanobacteria, and enable the materials to have both oxygen supply and sugar consumption functions.
[0032] The application of the engineered cyanobacteria provided by the present invention is aimed at the hypoxic and high-sugar environment of diabetic retinopathy. We have invented a new type of cyanobacteria that improves the microenvironment of diabetic retinopathy. The material is composed of cyanobacteria and two nanozymes. Since the eyes have good light transmittance, the cyanobacteria can produce oxygen in the eye under normal lighting conditions after the material is injected, effectively alleviating subretinal hypoxia. In addition, the two nanozymes loaded on the surface of the cyanobacteria have a cascade effect. First, they catalyze the degradation of excess glucose in the high-sugar environment to produce gluconic acid and hydrogen peroxide, but hydrogen peroxide, as a byproduct of active oxygen metabolism, can cause multiple adverse reactions in the body, and another enzyme loaded can degrade hydrogen peroxide to generate non-toxic water and oxygen. The degradation of glucose by the nanozyme with a cascade reaction has a certain mitigating effect on the high-sugar environment. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0034] Figure 1 This is a flow chart for preparing the engineered cyanobacteria provided in Example 1 of the present invention. DETAILED DESCRIPTION
[0035] The following examples are provided for a better understanding of the present invention, but are not intended to limit the best mode of implementation, nor to limit the content and protection scope of the present invention. Any product identical or similar to the present invention obtained by anyone under the inspiration of the present invention or by combining the features of the present invention with other prior arts shall fall within the protection scope of the present invention.
[0036] If no specific experimental steps or conditions are specified in the examples, the conventional experimental steps or conditions described in the literature in the field can be used. If no manufacturer is specified for the reagents or instruments used, they are all conventional reagent products that can be obtained commercially.
[0037] Example 1
[0038] This embodiment provides an engineered cyanobacteria, and its preparation process is as follows Figure 1 As shown, the specific preparation method is:
[0039] First, 5 mL of sodium citrate solution (4 mmol / L) and 45 mL of chloroauric acid solution (20 mmol / L) were mixed, heated and stirred in an oil bath at 140°C on a magnetic heating stirrer, and reacted for 30 minutes to obtain nano-gold with a diameter of 10 nm. 10 mL of polyethyleneimine with a concentration of 0.05 wt% was added under probe ultrasonic conditions, and ultrasonicated for 30 minutes. The reacted solution was heated at 10000 rpm for 30 minutes to obtain a pink-purple precipitate, which was washed several times with ultrapure water, and the precipitate was dried to obtain the modified nano-gold particle powder.
[0040] Mix 40 mL of iridium chloride solution (8.4 mmol / L) with 186 mL of polyvinyl pyrrolidone solution (186 mmol / L). Stir for 12 hours at room temperature using a magnetic stirrer to obtain a clear light yellow solution, then heat to 120°C and reflux for 6 hours until the solution turns brown. Heat and evaporate to completely remove the solvent, turning it into a black solid. Wash the precipitate three times with ultrapure water by centrifugation, and dry the precipitate to obtain iridium nanoparticle powder.
[0041] After centrifugation of the two nanoparticles, 4 mg of nano-gold powder and 1 mg of nano-iridium powder were taken and mixed with 100 mL of cyanobacteria solution (4 × 10 7 cells / mL, the solvent is ultrapure water) and stirred at a constant speed of 20-200rpm / min for 60min until the color of the solution changes from light green to dark green. After the nanoparticles and cyanobacteria are fully adsorbed, centrifuge at 3000rpm for 5min to obtain a dark green precipitate. The supernatant was taken and measured by inductively coupled plasma emission spectrometry (ICP-OES) to find that the supernatant did not contain gold and iridium, indicating that the material had been completely adsorbed. The precipitate was redissolved in 100mL ultrapure water to obtain a new engineered cyanobacteria solution that can improve the microenvironment of diabetic retinopathy.
[0042] Through testing and characterization of the above-mentioned new engineered cyanobacteria, field emission scanning electron microscopy tests showed that the two nanomaterials were regular spherical shapes, and elemental analysis showed that the two materials had been successfully adsorbed onto the surface of cyanobacteria.
[0043] The synthesized engineered blue was placed in darkness for 12 hours to remove the dissolved oxygen in the solution, and a 12W ordinary incandescent lamp was used as a stable light source to illuminate the cyanobacteria. The probe of the dissolved oxygen meter after zeroing was inserted into the solution to record the dissolved oxygen increment within 10 minutes. The dissolved oxygen meter tested that the material can continuously and stably produce oxygen under light conditions.
[0044] 5mL (10 8 The engineered cyanobacteria (500 cell / mL) was incubated with 5mL (100mM) glucose solution for 180min, and the supernatant was taken after centrifugation to verify the production of gluconic acid. The color reaction between gluconic acid, hydroxylamine and ferric chloride generates a red compound, and the ultraviolet absorption peak of gluconic acid appears at 505nm. At the same time, the pH of the solution continued to decrease during the reaction using a pH meter, which proved the production of gluconic acid and the glucose oxidase activity of the material. At the same time, the dissolved oxygen in the solution continued to rise using a dissolved oxygen meter, which was the hydrogen peroxide generated after the degradation of glucose, which was degraded into water and oxygen, proving the catalase activity of the material. The above experiments all show that the engineered cyanobacteria have good glucose oxidase activity and catalase activity.
[0045] The biocompatibility of the material was verified in cell experiments. 90 μL RPE (retinal pigment epithelial cells) and 10 μL engineered cyanobacteria (5×10 8 The engineered cyanobacteria were co-incubated with 50% cyanobacteria (100 μg / mL) for 24 hours. The cell survival rate was 90% using the CCK-8 kit (Cell Counting Kit-8) and cell death and liveness staining experiments. In the flow cytometry experiment, the apoptosis rate of the cells was 8% after the materials were co-incubated with the cells for 24 hours. These results prove that the engineered cyanobacteria have low biotoxicity and good biocompatibility.
[0046] Example 2
[0047] This embodiment provides an engineered cyanobacteria, and the preparation method thereof is as follows:
[0048] First, 5 mL of sodium borohydride solution (2 mmol / L) and 45 mL of chloroauric acid solution (20 mmol / L) were stirred and heated at 300 rpm for 1 min. After the solution turned bright red, L-cysteine (0.1 mmol / L) was added and heated to 100 °C with a magnetic stirrer for 1 h to obtain modified gold nanoparticles.
[0049] 5 mL of chloroplatinic acid (5 mmol / L) and 45 mL of sodium borohydride (1 mmol / L) were mixed, heated to 50° C. with stirring on a magnetic stirrer and reacted for 6 h to obtain platinum nanoparticles.
[0050] After centrifugation of the two nanoparticles, 4 mg of nano-gold powder and 1 mg of nano-platinum powder were taken and mixed with 100 mL of cyanobacteria solution (4 × 10 7 cells / mL, the solvent is ultrapure water) and stirred at a constant speed of 20-200rpm / min for 60min until the color of the solution changes from light green to dark green. After the nanoparticles and cyanobacteria are fully adsorbed, centrifuge at 3000rpm for 5min to obtain a dark green precipitate. The supernatant was taken and measured by inductively coupled plasma emission spectrometry (ICP-OES) to find that there was no gold and platinum in the supernatant, indicating that the material had been completely adsorbed. The precipitate was redissolved in 100mL ultrapure water to obtain a new engineered cyanobacteria solution that can improve the microenvironment of diabetic retinopathy.
[0051] By testing and characterizing the above-mentioned new engineered cyanobacteria, field emission scanning electron microscopy tests showed that the two nanomaterials were regular spherical shapes, and elemental analysis showed that the two materials had been successfully adsorbed onto the surface of the cyanobacteria.
[0052] 5mL (10 8 cell / mL) engineered cyanobacteria were incubated with 5mL (100mM) glucose for 180min, and the supernatant was taken after centrifugation to verify the production of gluconic acid. The color reaction between gluconic acid, hydroxylamine and ferric chloride generates a red compound, and the ultraviolet absorption peak of gluconic acid appears at 505nm. At the same time, the pH of the solution during the reaction was continuously reduced using a pH meter, which proved the generation of gluconic acid. However, the catalytic efficiency of the material is compared with that of Example 1, and the catalytic activity is reduced. At the same time, the dissolved oxygen in the solution measured by a dissolved oxygen meter continued to rise slowly. The material has certain glucose oxidase and catalase activities, but the activity is relatively low.
[0053] The biocompatibility of the material was verified in cell experiments. 90 μL RPE (retinal pigment epithelial cells) and 10 μL engineered cyanobacteria (5×10 8 The cells were incubated with the material for 24 hours, and the cell survival rate was 85% using the CCK-8 kit (Cell Counting Kit-8) and cell death and liveness staining experiments. In the flow cytometry experiment, it was measured that after the material and cells were incubated for 24 hours, the cell apoptosis rate was 15%.
[0054] Example 3
[0055] This embodiment provides an engineered cyanobacteria, and the preparation method thereof is as follows:
[0056] First, 40 mL of ascorbic acid (4 mmol / L) and 20 mL of chloroauric acid solution (20 mmol / L) were mixed, heated and stirred in an oil bath at 140°C on a magnetic heating stirrer, and reacted for 30 minutes to obtain nanogold with a diameter of about 25 nm. 5 mL of 0.05 wt% mercaptoethylamine was added under probe ultrasonic conditions, and ultrasonicated for 30 minutes to obtain modified nanogold particles.
[0057] Mix 20 mL potassium permanganate solution (0.1 mol / L) and 30 mL anhydrous manganese acetate (0.2 mol / L) in a ratio of 2:3. Stir for 12 h at room temperature using a magnetic stirrer, then heat to 120 °C and reflux for 6 h to obtain manganese dioxide nanoparticles. Heat and evaporate to completely remove the solvent to form a black solid. Wash the precipitate three times with ultrapure water by centrifugation, and dry the precipitate to obtain manganese dioxide nanoparticle powder.
[0058] After centrifugation of the two nanoparticles, 4 mg of nano-gold powder and 1 mg of nano-manganese dioxide powder were taken and mixed with 100 mL of cyanobacteria solution (4 × 10 7 cells / mL, the solvent is ultrapure water) and stirred at a constant speed of 20-200rpm / min for 60min until the color of the solution changes from light green to dark green. After the nanoparticles and cyanobacteria are fully adsorbed, centrifuge at 3000rpm for 5min to obtain a dark green precipitate. The supernatant was taken and measured by inductively coupled plasma emission spectrometry (ICP-OES) to find that the supernatant did not contain gold and manganese elements, indicating that the material has been completely adsorbed. The precipitate was redissolved in 100mL ultrapure water to obtain a new engineered cyanobacteria solution that can improve the microenvironment of diabetic retinopathy.
[0059] Through testing and characterization of the above-mentioned new engineered cyanobacteria, field emission scanning electron microscopy tests showed that the two nanomaterials were regular spherical shapes, and elemental analysis showed that the two materials had been successfully adsorbed onto the surface of cyanobacteria.
[0060] 5mL (10 8cell / mL) engineered cyanobacteria were incubated with 5mL (100mM) glucose for 180min, and the supernatant was taken after centrifugation to verify the production of gluconic acid. The color reaction between gluconic acid, hydroxylamine and ferric chloride generates a red compound, and the ultraviolet absorption peak of gluconic acid appears at 505nm. At the same time, the pH of the solution during the reaction was continuously reduced using a pH meter, which proved the generation of gluconic acid. However, the catalytic efficiency of the material is compared with that of Example 1, and the catalytic activity is reduced. At the same time, the dissolved oxygen in the solution measured by a dissolved oxygen meter continued to rise slowly. The material has certain glucose oxidase and catalase activities, but the activity is relatively low.
[0061] The biocompatibility of the material was verified in cell experiments. 90 μL RPE (retinal pigment epithelial cells) and 10 μL engineered cyanobacteria (5×10 8 The cells were co-incubated with the material for 24 hours. The cell survival rate was 75% using the CCK-8 kit and cell death and viability staining experiments. The apoptosis rate of the cells was 20% after the material and cells were co-incubated for 24 hours using the flow cytometry experiment.
[0062] Example 4
[0063] This embodiment provides an engineered cyanobacteria, and the preparation method thereof is as follows:
[0064] First, 40 mL of ascorbic acid (4 mmol / L) and 20 mL of chloroauric acid solution (20 mmol / L) were mixed, heated and stirred in an oil bath at 140°C on a magnetic heating stirrer, and reacted for 30 minutes to obtain nanogold with a diameter of about 25 nm. 5 mL of 0.05 wt% mercaptoethylamine was added under probe ultrasonic conditions, and ultrasonicated for 30 minutes to obtain modified nanogold particles.
[0065] 40 mL of ascorbic acid (4 mmol / L) and 20 mL of copper chloride solution (20 mmol / L) were mixed, heated and stirred in an oil bath at 80° C. on a magnetic heating stirrer, and reacted for 30 minutes to obtain nano-copper with a diameter of about 25 nm.
[0066] After centrifugation of the two nanoparticles, 4 mg of nano-gold powder and 1 mg of nano-copper powder were taken and mixed with 100 mL of cyanobacteria solution (4 × 10 7cells / mL, the solvent is ultrapure water) and stirred at 20-200rpm / min for 60min until the color of the solution changes from light green to dark green. After the nanoparticles and cyanobacteria are fully adsorbed, centrifuge at 3000rpm for 5min to obtain a dark green precipitate. The supernatant was taken and measured by inductively coupled plasma emission spectrometry (ICP-OES) to find that the supernatant did not contain gold and copper elements, indicating that the material has been completely adsorbed. The precipitate was redissolved in 100mL ultrapure water to obtain a new engineered cyanobacteria solution that can improve the microenvironment of diabetic retinopathy.
[0067] 5mL (10 8 cell / mL) engineered cyanobacteria were incubated with 5mL (100mM) glucose solution for 180min, and the supernatant was taken after centrifugation to verify the production of gluconic acid. The color reaction between gluconic acid, hydroxylamine and ferric chloride generates a red compound, and the ultraviolet absorption peak of gluconic acid appears at 505nm. At the same time, the pH of the solution during the reaction was measured using a pH meter, which continuously decreased, all of which proved the generation of gluconic acid. However, the catalytic efficiency of the material is compared with that of Example 1, and the catalytic activity is reduced. At the same time, the dissolved oxygen in the solution measured using a dissolved oxygen meter continued to rise slowly. The material has certain glucose oxidase and catalase activities, but the activity is relatively low.
[0068] The biocompatibility of the material was verified in cell experiments. 90 μL RPE (retinal pigment epithelial cells) and 10 μL engineered cyanobacteria (5×10 8 The cells were incubated with the material for 24 hours, and the cell survival rate was 80% using the CCK-8 kit (Cell Counting Kit-8) and cell death and liveness staining experiments. In the flow cytometry experiment, it was measured that after the material and cells were incubated for 24 hours, the cell apoptosis rate was 15%.
[0069] Example 5
[0070] This embodiment provides an engineered cyanobacteria, and the preparation method thereof is as follows:
[0071] First, 40 mL of ascorbic acid (4 mmol / L) and 20 mL of chloroauric acid solution (20 mmol / L) were mixed, heated and stirred in an oil bath at 140°C on a magnetic heating stirrer, and reacted for 30 minutes to obtain nanogold with a diameter of about 25 nm. 5 mL of 0.05 wt% mercaptoethylamine was added under probe ultrasonic conditions, and ultrasonicated for 30 minutes to obtain modified nanogold particles.
[0072] The same concentration of Fe 2+ of saline solution with 30 mL Fe 3+The salt solution is mixed and heated to 50° C., PEG 20,000 (polyethylene glycol 20,000) is added as a surfactant, and ammonia water is added as a precipitant, and the pH of the reaction solution is adjusted to 11 to obtain ferrosoferric oxide nanoparticles.
[0073] After centrifugation of the two nanoparticles, 4 mg of nano-gold powder and 1 mg of nano-ferroferric oxide powder were taken and mixed with 100 mL of cyanobacteria solution (4 × 10 7 cells / mL, the solvent is ultrapure water) and stirred at a constant speed of 20-200rpm / min for 60min until the color of the solution changes from light green to dark green. After the nanoparticles and cyanobacteria are fully adsorbed, centrifuge at 3000rpm for 5min to obtain a dark green precipitate. The supernatant was taken and measured by inductively coupled plasma emission spectrometry (ICP-OES) to find that the supernatant did not contain gold and iron elements, indicating that the material has been completely adsorbed. The precipitate was redissolved in 100mL ultrapure water to obtain a new engineered cyanobacteria solution that can improve the microenvironment of diabetic retinopathy.
[0074] 5mL (10 8 cell / mL) engineered cyanobacteria were incubated with 5mL (100mM) glucose solution for 180min, and the supernatant was taken after centrifugation to verify the production of gluconic acid. The color reaction between gluconic acid, hydroxylamine and ferric chloride generates a red compound, and the ultraviolet absorption peak of gluconic acid appears at 505nm. At the same time, the pH of the solution during the reaction was measured using a pH meter, which continuously decreased, all of which proved the generation of gluconic acid. However, the catalytic efficiency of the material is compared with that of Example 1, and the catalytic activity is reduced. At the same time, the dissolved oxygen in the solution measured using a dissolved oxygen meter continued to rise slowly. The material has certain glucose oxidase and catalase activities, but the activity is relatively low.
[0075] The biocompatibility of the material was verified in cell experiments. 90 μL RPE (retinal pigment epithelial cells) and 10 μL engineered cyanobacteria (5×10 8 The cells were incubated with the material for 24 hours, and the cell survival rate was 80% using the CCK-8 kit (Cell Counting Kit-8) and cell death and liveness staining experiments. In the flow cytometry experiment, the apoptosis rate of the cells was 20% after the material and cells were incubated for 24 hours.
[0076] Comparative Example 1
[0077] This comparative example provides an engineered cyanobacteria, the preparation method of which is as follows:
[0078] First, 40 mL of ascorbic acid (4 mmol / L) and 20 mL of chloroauric acid solution (20 mmol / L) were mixed, heated and stirred in an oil bath at 140°C on a magnetic heating stirrer, and reacted for 30 minutes to obtain nanogold with a diameter of about 25 nm. 5 mL of 0.05 wt% mercaptoethylamine was added under probe ultrasonic conditions, and ultrasonicated for 30 minutes to obtain modified nanogold particles.
[0079] After the nanoparticles were centrifuged, 5 mg of gold nanoparticles were mixed with 100 mL of cyanobacteria culture medium (5 × 10 5 cells / mL, the solvent is ultrapure water) and stirred at 20-200rpm / min for 60min until the color of the solution changes from light green to dark green. After the nanoparticles and cyanobacteria are fully adsorbed, centrifuge at 3000rpm for 5min to obtain a dark green precipitate. Take the supernatant and use an inductively coupled plasma emission spectrometer (ICP-OES) to measure that there is no gold element in the supernatant, indicating that the material has been completely adsorbed. The precipitate is redissolved in 100mL ultrapure water to obtain an engineered cyanobacteria solution.
[0080] 5mL (10 8 The engineered cyanobacteria (100 mM, 100 mM) of glucose solution (500 mM) were incubated with 5 mL (100 mM) glucose solution for 180 min, and the supernatant was taken after centrifugation to verify the production of gluconic acid. The color reaction between gluconic acid, hydroxylamine and ferric chloride generates a red compound, and the ultraviolet absorption peak of gluconic acid appears at 505 nm. At the same time, the pH of the solution continued to decrease during the reaction using a pH meter. However, the hydrogen peroxide content in the environment continued to rise, indicating that the hydrogen peroxide generated during the degradation of glucose was not catalyzed and the material did not have catalase activity.
[0081] Comparative Example 2
[0082] This comparative example provides an engineered cyanobacteria, the preparation method of which is as follows:
[0083] Mix 20 mL potassium permanganate solution (0.1 mol / L) and 30 mL anhydrous manganese acetate (0.2 mol / L) in a ratio of 2:3. Stir for 12 h at room temperature using a magnetic stirrer, then heat to 120 °C and reflux for 6 h to obtain manganese dioxide nanoparticles. Heat and evaporate to completely remove the solvent to form a black solid. Wash the precipitate three times with ultrapure water by centrifugation, and dry the precipitate to obtain manganese dioxide nanoparticle powder.
[0084] After the nanoparticles were centrifuged, 5 mg of nanomanganese dioxide powder was mixed with 100 mL of cyanobacteria solution (4 × 10 7cells / mL, the solvent is ultrapure water) and stirred at 20-200rpm / min for 60min until the color of the solution changes from light green to dark green. After the nanoparticles and cyanobacteria are fully adsorbed, centrifuge at 3000rpm for 5min to obtain a dark green precipitate. Take the supernatant and use an inductively coupled plasma emission spectrometer (ICP-OES) to measure that there is no manganese in the supernatant, indicating that the material has been completely adsorbed. The precipitate is redissolved in 100mL ultrapure water to obtain an engineered cyanobacteria solution.
[0085] 5mL (10 8 The engineered cyanobacteria (500 cells / mL) were incubated with 5 mL (100 mM) glucose solution for 180 min, and the supernatant was taken after centrifugation to verify the production of gluconic acid. No obvious gluconic acid UV absorption peak appeared at 505 nm, and the pH meter measured no obvious change in the solution pH during the reaction, indicating that the material had no obvious glucose oxidase activity.
[0086] Animal testing
[0087] STZ (streptozotocin) was used to construct a diabetic mouse model. In this study, 5-week-old C57BL / 6J (B6) male mice were purchased uniformly, with ten mice in each group. They were raised normally, had free access to national standard mixed feed and filtered tap water, and the temperature in the breeding room was maintained at 22-28°C, the relative humidity was maintained at 40-60%, and the light and dark alternation time was 12 / 12h. STZ was dissolved in ultrapure water at a concentration of 6mg / mL and intraperitoneally injected into mice at a dose of 55mg / kg for one week. The blood glucose of STZ-modeled type 1 diabetic mice was >16.5mmol / L.
[0088] Fundus fluorescence angiography was performed every two weeks to observe the condition of the retina. When the mice were suffering from diabetes for seven weeks, fundus leakage occurred. At this time, the mice were treated with subretinal injection of materials (engineered cyanobacteria obtained in various embodiments of the present invention), and the subretinal injection volume was 1 μL per eyeball. Fundus fluorescence angiography was performed in the second week after the injection of engineered cyanobacteria. The leakage area of the experimental group injected with engineered cyanobacteria was significantly reduced, indicating that the leakage situation was effectively improved. The leakage area of the mice in the control group (injected with the same volume of normal saline) increased, indicating that the leakage situation further worsened. At the ninth week, no fundus hemorrhage was found in all groups of mice. After taking the above-mentioned mouse eyeball slices and immunostaining, it can be observed that the retinal structure of the mice is intact and there is no retinal detachment.
[0089] Obviously, the above embodiments are merely examples for the purpose of clear explanation, and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived from these are still within the scope of protection of the invention.
Claims
1. An engineered cyanobacteria with glucose-lowering and oxygen-producing functions, characterized in that: It comprises cyanobacteria and nanoparticles adsorbed on the surface of cyanobacteria, wherein the nanoparticles are nanogold particles and nanoparticles with catalase activity; The nanoparticles having catalase activity are iridium nanoparticles; Every 10 7 The amount of gold nanoparticles adsorbed on each cyanobacteria is 20μg-80μg; Every 10 7 The amount of the nanoparticles having catalase activity adsorbed on each cyanobacteria is 10 μg-100 μg; The method for preparing the engineered cyanobacteria with the functions of reducing blood sugar and producing oxygen comprises the following steps: The nano-gold is modified by a modifying agent to obtain nano-gold particles with positive surface charge; Adding the obtained nano-gold particles and nano-particles with catalase activity to a culture solution containing cyanobacteria, adsorbing and separating the solid from the liquid, and dispersing the obtained solid in ultrapure water to obtain the engineered cyanobacteria; The method for preparing the nano-gold comprises: using chloroauric acid as a raw material and using a reducing agent to perform a reduction reaction to obtain the nano-gold; The reducing agent is sodium citrate; The modifying agent is polyethyleneimine.
2. The engineered cyanobacteria with glucose-lowering and oxygen-producing functions according to claim 1, characterized in that: The concentration of the modifier is 0.01 wt% – 0.5 wt%; The solvent in the modifying agent is ultrapure water.
3. The engineered cyanobacteria with glucose-lowering and oxygen-producing functions according to claim 1, characterized in that: The temperature of the reduction reaction is 90-120° C. and the time is 30-60 min.
4. The engineered cyanobacteria with glucose-lowering and oxygen-producing functions according to claim 1, characterized in that: The concentration of the reducing agent is 10 mmol / L-100 mmol / L.
5. The engineered cyanobacteria with glucose-lowering and oxygen-producing functions according to claim 1, characterized in that: In the cyanobacteria culture solution, the cyanobacteria concentration is 10 5 -10 9 cells / mL; The adsorption step lasts for 30-90 min; The concentration of cyanobacteria in the engineered cyanobacteria is 10 5 -10 9 cells / mL.
6. An engineered cyanobacteria with glucose-lowering and oxygen-producing functions, characterized in that: It comprises cyanobacteria and nanoparticles adsorbed on the surface of cyanobacteria, wherein the nanoparticles are nanogold particles and nanoparticles with catalase activity; The nanoparticles having catalase activity are platinum nanoparticles; Every 10 7 The amount of gold nanoparticles adsorbed on each cyanobacteria is 20μg-80μg; Every 10 7 The amount of the nanoparticles having catalase activity adsorbed on each cyanobacteria is 10 μg-100 μg; The method for preparing the engineered cyanobacteria with the functions of reducing blood sugar and producing oxygen comprises the following steps: The nano-gold is modified by a modifying agent to obtain nano-gold particles with positive surface charge; Adding the obtained nano-gold particles and nano-particles with catalase activity to a culture solution containing cyanobacteria, adsorbing and separating the solid from the liquid, and dispersing the obtained solid in ultrapure water to obtain the engineered cyanobacteria; The method for preparing the nano-gold comprises: using chloroauric acid as a raw material and using a reducing agent to perform a reduction reaction to obtain the nano-gold; The reducing agent is sodium borohydride; The modifier is L-cysteine.
7. The engineered cyanobacteria with glucose-lowering and oxygen-producing functions according to claim 6, characterized in that: The concentration of the modifier is 0.01 wt% – 0.5 wt%; The solvent in the modifying agent is ultrapure water.
8. The engineered cyanobacteria with glucose-lowering and oxygen-producing functions according to claim 6, characterized in that: The temperature of the reduction reaction is 90-120° C. and the time is 30-60 min.
9. The engineered cyanobacteria with glucose-lowering and oxygen-producing functions according to claim 6, characterized in that: The concentration of the reducing agent is 10 mmol / L-100 mmol / L.
10. The engineered cyanobacteria with glucose-lowering and oxygen-producing functions according to claim 6, characterized in that: In the cyanobacteria culture solution, the cyanobacteria concentration is 10 5 -10 9 cells / mL; The adsorption step lasts for 30-90 min; The concentration of cyanobacteria in the engineered cyanobacteria is 10 5 -10 9 cells / mL.
11. Use of the engineered cyanobacteria with hypoglycemic and oxygen-producing functions as claimed in any one of claims 1 to 5 or the engineered cyanobacteria with hypoglycemic and oxygen-producing functions as claimed in any one of claims 6 to 10 in the preparation of a drug for treating diabetic retinopathy.
Citation Information
Patent Citations
Novel method of improving tumor hypoxia
CN110893196A
Method for increasing oxygen production by blue algae endocytosing up-conversion nanoparticles
CN111088293A
Preparation method of up-conversion nanoparticles and nano-photosynthesis system
CN111518560A
Near-infrared driven self-oxygen-supply compound, and preparation method and application thereof
CN111714631A
